Previous close | 3.3000 |
Open | 2.9000 |
Bid | 2.6000 |
Ask | 2.8500 |
Strike | 92.50 |
Expiry date | 2023-04-21 |
Day's range | 2.8200 - 2.9000 |
Contract range | N/A |
Volume | |
Open interest | 545 |
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Bicycle (BCYC) and Novartis enter into a collaboration agreement to develop, manufacture and commercialize conjugate drugs for several oncology indications. Stock soars following the news.
Novartis (NVS) Kisqali meets primary endpoint of invasive disease-free survival in certain patients with early breast cancer at risk of recurrence.